*Offer valid only for commercially insured patients. Commercially insured patients whose insurance does not cover Zyclara may pay more. Cash paying patients are not eligible. Not valid for patients reimbursed by federal health care programs, including Medicare, Medicaid, CHAMPUS, the Department of Veterans Affairs, state maternal and child health block grant programs under 42 U.S.C. 701 et. seq., state social service block grant programs under 42 U.S.C. section 1397 et. seq., or any other similar federal or state healthcare program. Void where prohibited by law, taxed or restricted. Void outside the United States. Valeant Pharmaceuticals reserves the right to rescind, revoke or amend this offer at any time. See savings card for full eligibility terms and conditions.
ZYCLARA Cream 3.75% is a prescription medicine for skin use only (topical) to treat actinic keratosis (AK) on the full face or balding scalp in adults with a normal immune function
Not everyone will have the same response to ZYCLARA Cream
It’s important to stay on ZYCLARA Cream as directed by your physician
At the end of your treatment, you should have fewer lesions than before beginning ZYCLARA Cream
ZYCLARA® (imiquimod) Cream, 3.75% is a prescription medicine for use on the skin only (topical) to treat actinic keratosis (AK) on the full face or balding scalp in adults with a normal immune system.
It is not known if ZYCLARA Cream is safe and effective for the topical treatment of AK in children less than 18 years of age, for more than one 2-cycle treatment course in the same affected area, or in patients with extreme sensitivity to sunlight.
IMPORTANT SAFETY INFORMATION
Do not get ZYCLARA Cream in or near your eyes, in or on your lips, or in your nose. If you get ZYCLARA Cream in your mouth, eyes or nose, rinse well with water right away.
When using ZYCLARA Cream do not use sunlamps or tanning beds, and avoid sunlight as much as possible. Use sunscreen and wear protective clothing if you go outside during daylight. If covering the treated area, cotton gauze dressings can be used.
Tell your healthcare professional about all the medicines you take, especially if you have had other treatments for actinic keratosis or if you are or plan to become pregnant or are nursing. ZYCLARA Cream should not be used until your skin has healed from other treatments. Do not use ZYCLARA Cream with other products containing the same active ingredient because of increased risk of side effects.
ZYCLARA Cream may cause serious side effects, including skin drainage (weeping) or breakdown of the outer layer of the skin (erosion). You may need to stop using ZYCLARA until the skin is healed. You should not use ZYCLARA until the skin has healed from any other treatments. ZYCLARA Cream may also cause flu-like symptoms. Tell your healthcare professional if you have tiredness, nausea, vomiting, fever, chills, muscle pain, and joint pain.
The most common side effects of ZYCLARA Cream include local skin reactions including: skin redness, scabbing, crusting, flaking,scaling, dryness, and swelling; headache, itching in the treatment area, tiredness, nausea, skin irritation, and pain at the treatment site. Tell your healthcare professional if you have any side effect that bothers you or that does not go away.
You are encouraged to report negative side effects of prescription drugs to the FDA.